Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
ThermoGenesis Holdings, Inc. See All Filings	D	2023-03-28 10:04:37 UTC
Amount To Be Raised $3,000,001 Associated Brokers / Dealers H.C. Wainwright & Co., LLC. CIK Number 0000811212 Filed Document 0000897069-23-000189 Exclusions or Exemptions 506b Accepted Date 2023-03-28 10:04:37 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CESCA THERAPEUTICS INC. See All Filings	D	2019-02-13 18:32:02 UTC
Amount To Be Raised $800,000 Associated Brokers / Dealers N/A CIK Number 0000811212 Filed Document 0000811212-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-02-13 18:32:02 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets $$5,000,001 - $25,000,000 Type of Security Equity
CESCA THERAPEUTICS INC. See All Filings	D	2018-04-12 10:24:28 UTC
Amount To Be Raised $816,912 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0000811212 Filed Document 0000897069-18-000240 Exclusions or Exemptions 506b Accepted Date 2018-04-12 10:24:28 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
CESCA THERAPEUTICS INC. See All Filings	D	2016-02-24 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0000811212 Filed Document 0001437749-16-026085 Exclusions or Exemptions 506b Accepted Date 2016-02-24 00:00:00 UTC Type of Offering D Industry Other Health Care Principal Place of Business CALIFORNIA Revenue or Assets $$5,000,001 - $25,000,000 Type of Security Equity
CESCA THERAPEUTICS INC. See All Filings	D	2015-09-03 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0000811212 Filed Document 0000811212-15-000027 Exclusions or Exemptions 506b Accepted Date 2015-09-03 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt